SUBSCRIPTION AGREEMENT Bioadaptives, Inc. NOTICE TO INVESTORSSubscription Agreement • March 4th, 2022 • Bioadaptives, Inc. • Pharmaceutical preparations • Nevada
The securities of Bioadaptives, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. Investors should further understand that this investment is illiquid and is expected to continue to be illiquid for an indefinite period of time. No public market exists for the securities to which this Subscription Agreement relates.
EMPLOYMENT CONTRACTEmployment Agreement • March 4th, 2022 • Bioadaptives, Inc. • Pharmaceutical preparations • Nevada
THIS EMPLOYMENT AGREEMENT is made this 1st day of June, 2021(the Effective Date”), between BIOADAPTIVES, INC. (hereinafter referred to as "Employer", or the Company), a Delaware corporation with it principal place of business in Las Vegas, Nevada and ROBERT W. ELLIS (hereinafter referred to as "Employee") who resides in Riverview, Florida. In consideration of the mutual covenants contained in this Agreement, the Employer and the Employee hereby agree as follows:
EMPLOYMENT CONTRACTEmployment Contract • March 4th, 2022 • Bioadaptives, Inc. • Pharmaceutical preparations • Nevada
THIS EMPLOYMENT CONTRACT is made effective July 1, 2021 (the Effective Date”), between BIOADAPTIVES, INC. (hereinafter referred to as “Employer”, or the Company), a Delaware corporation with it principal place of business in Las Vegas, Nevada and Dr. Edward E. Jacobs (hereinafter referred to as “Employee”) who resides in Las Vegas, Nevada. In consideration of the mutual covenants contained in this Agreement, the Employer and the Employee hereby agree as follows:
